ACLAX | VMVAX | ACLAX / VMVAX | |
Total Expense Ratio | 1.22 | 0.07 | 1,743% |
Annual Report Gross Expense Ratio | 1.22 | 0.07 | 1,743% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 8.315 | 6.631 | 125% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 32B | 22% |
Annual Yield % from dividends | 1.25 | 2.15 | 58% |
Returns for 1 year | 1.49 | 7.99 | 19% |
Returns for 3 years | 7.25 | 23.83 | 30% |
Returns for 5 years | 18.87 | 68.49 | 28% |
Returns for 10 years | 19.92 | 102.77 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DIEAX | 44.50 | 0.43 | +0.98% |
BNY Mellon International Core Equity A | |||
CNWCX | 87.48 | 0.35 | +0.40% |
American Funds New World 529C | |||
LMCSX | 33.85 | 0.01 | +0.03% |
Lord Abbett Mid Cap Stock R4 | |||
BQLCX | 23.28 | N/A | N/A |
Bright Rock Quality Large Cap Instl | |||
GQEIX | 21.62 | -0.14 | -0.64% |
GQG Partners US Select Quality Eq Instl |